|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.260 0.000 (0.000%) | 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 352,150 | 118.651% | 377,168 | 370,069 | 773,654 | 1,007,186 |
| Cost of Sales | (316,494) | 126.187% | (341,164) | (335,888) | (723,241) | (917,001) |
| Gross Profit | 35,656 | 68.746% | 36,004 | 34,181 | 50,413 | 90,185 |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (1,748) | (58,149) | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,321) | -70.354% | (8,931) | (78,167) | (5,698) | 3,777 | |
| Taxation | (2,425) | 30.940% | (1,770) | 12,460 | (4,364) | (5,167) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (193) | -68.204% | (3,922) | 21,495 | (5,371) | (20,155) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (5,939) | -56.526% | (14,623) | (44,212) | (15,433) | (21,545) | |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 5,045 | -51.364% | 13,647 | 17,897 | 17,076 | 20,924 |
| Depreciation & Amortisation | 2,626 | -67.783% | 13,177 | 11,359 | 14,062 | 16,198 |
| Directors' Emoluments | -- | -- | 1,604 | 2,232 | 1,549 | 4,737 |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -3.330 | -58.218% | -8.430 | -25.780 | -9.100 | -12.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.008 | 0.304 | 0.289 | 0.029 |
| NBV per share ($) | (0.357) | -- | (0.510) | (0.462) | (0.204) | (0.224) |
| Remarks: | Real time quote last updated: 04/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -5,939 |
| %Change | -56.526% |
| EPS / (LPS) | HKD -0.033 |
| NBV Per Share ($) | HKD -0.357 |